Skip to main content
Clear icon
50º
Join Insider
Trending
Houston Rodeo updates dress code policy during final week of RodeoHouston. Here’s what you need to know before you go
Spring Break chaos hits Houston streets and businesses
Here are the ships participating in the first Fleet Week in Houston
Suspect dead, 3 hospitalized after police pursuit leads to violent wreck with truck in Texas City
Amtrak passenger train with over 100 on board crashes into 18-wheeler in Missouri City
3, including toddler, hospitalized after major crash in N. Harris County; at-fault driver flees scene
Rodeo attire sparks online debate: Should Houston rodeo enforce a dress code?
Military veteran charged with capital murder after his estranged wife, her mother shot to death in Montgomery County
Judge extends Texas school voucher application deadline after lawsuit over exclusion of Islamic schools
Rowdy crowds prompt early closure of Houston Rodeo carnival Saturday night

Health

FDA has fast-tracked promising drug to treat COVID-19 patients and it is in trial at Houston Methodist

KPRC 2 Staff

File

HOUSTON – The U.S. Food and Drug Administration has fast-tracked a promising drug to treat COVID-19 patients and it is in trial at Houston Methodist Hospital.

The drug is called RLF-100 and is also known as aviptadil. It has been approved by the FDA for emergency use at multiple clinical sites in patients who are too ill to enter the FDA’s Phase 2/3 trials.

Recommended Videos

According to a press release from the drug maker NeuroRX, independent researchers have reported that aviptadil blocked replication of the SARS coronavirus in human lung cells and monocytes.

The drug has been successful in reducing lung inflammation and so the FDA now says any doctor at any hospital can request this treatment to help severely ill COVID-19 patients.

To learn more about the RLF-100, click here.

Correction:

This story was not up to KPRC 2's journalistic standards. It has since been updated with confirmed information.

Copyright 2020 by KPRC Click2Houston - All rights reserved.